首页> 外文期刊>Toxicology in vitro: an international journal published in association with BIBRA >Comparative analysis of Rapid Equilibrium Dialysis (RED) and solid phase micro-extraction (SPME) methods for In Vitro-In Vivo extrapolation of environmental chemicals
【24h】

Comparative analysis of Rapid Equilibrium Dialysis (RED) and solid phase micro-extraction (SPME) methods for In Vitro-In Vivo extrapolation of environmental chemicals

机译:快速平衡透析(红色)和固相微萃取(SPME)方法对环境化学品体内外推的比较分析

获取原文
获取原文并翻译 | 示例
           

摘要

In vitro to in vivo extrapolation (IVIVE) is a critical component of the efforts to prioritize and assess environmental chemicals using high-throughput in vitro assays. The plasma unbound fraction (F-ub) is a key toxicokinetic parameter in IVIVE, and is usually measured via the Rapid Equilibrium Dialysis (RED) assay widely used for pharmaceuticals. However, pharmaceuticals have a narrower range of physicochemical properties than environmental chemicals. Motivated by the observation that high LogK(OW) compounds appeared to have disproportionately low F-ub measurements using RED, we added a protein-free control in order to verify equilibration to 100% unbound in the absence of proteins. We found that many high LogK(OW) non-pharmaceuticals fail to equilibrate in RED in protein-free controls, and thus had apparent values of F-ub = 0 in plasma. In these cases, Solid Phase Microextraction (SPME) as an alternative method provided an accurate, though more time-consuming, alternative to accurately determine F-ub. We propose an updated IVIVE workflow that adds a protein-free control to the RED protocol, with the use of alternative approaches, such as SPME, in cases where compounds fail to adequately equilibrate. These refinements will provide additional confidence in the use of IVIVE as part of high-throughput screening programs of chemicals.
机译:体内外推(vive)是使用高通量在体外测定的优先考虑和评估环境化学品的努力的关键组成部分。等离子体未结合级分(F-UB)是vive中的关键诱导参数,通常通过广泛用于药物的快速平衡透析(红色)测定来测量。然而,药品的物理化学性质范围较窄,而不是环境化学品。通过观察到的是,使用红色的高碱基(OW)化合物似乎具有不成比例的低F-UB测量,我们加入了无蛋白质对照,以便在没有蛋白质的情况下验证到100%未结合的平衡。我们发现许多高逻辑(OW)非药物未在无蛋白质对照中以红色平衡,因此血浆中具有F-UB = 0的表观值。在这些情况下,固相微萃取(SPME)作为替代方法提供了准确的准确耗时的准确性,替代方法是准确地确定F-UB。我们提出了更新的常识工作流程,该流程为红色方案增加了无蛋白质控制,使用替代方法,例如SPME,在化合物未能充分平衡的情况下。这些改进将为使用vive提供额外的信心,作为化学品的高通量筛选计划的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号